SLC5A1 and diabetes mellitus: Unfortunately, it was also found that phlorizin lacks any therapeutic potential as a treatment for patients with diabetes due to its poor oral absorption and the fact that SGLT1 is an intestinal sodium-dependent glucose co-transporter, and, as such, its blockage causes diarrhea [122].